References
- Kessous R, Shoham-Vardi I, Pariente G, et al. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart. 2015;101(6):442–446.
- Farahvar S, Walfisch A, Sheiner E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review. Expert Rev Endocrinol Metab. 2019;14(1):63–74.
- Shalom G, Shoham-Vardi I, Sergienko R, et al. Is preeclampsia a significant risk factor for long-term hospitalizations and morbidity? J Matern-Fetal Neonatal Med. 2013;26(1):13–15.
- Bellamy L, Casas J-P, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779.
- Beharier O, Shoham-Vardi I, Pariente G, et al. Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease. J Clin Endocrinol Metab. 2015;100(4):1412–1416.
- Beharier O, Sergienko R, Kessous R, et al. Gestational diabetes mellitus is a significant risk factor for long-term ophthalmic morbidity. Arch Gynecol Obstet. 2017;295(6):1477–1482.
- Goueslard K, Cottenet J, Mariet A-S, et al. Early cardiovascular events in women with a history of gestational diabetes mellitus. Cardiovasc Diabetol. 2016;15(1):15.
- Kessous R, Shoham-Vardi I, Pariente G, et al. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart. 2013;99(15):1118–1121.
- Rich-Edwards JW, Fraser A, Lawlor DA, et al. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health? Epidemiol Rev. 2014;36(1):57–70.
- Hashemi S, Ramezani Tehrani F, Mehrabi Y, et al. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran lipid and glucose study). J Obstet Gynaecol Res. 2013;39(5):891–897.
- Beharier O, Davidson E, Sergienko R, et al. Preeclampsia and future risk for maternal ophthalmic complications. Am J Perinatol. 2016;33(07):703–707.
- Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497.
- Ballas J, Moore TR, Ramos GA. Management of diabetes in pregnancy. Curr Diab Rep. 2012;12(1):33–42.
- Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update. Circulation. 2011;123(11):1243–1262.
- Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women. Stroke. 2014;45(5):1545–1588.
- Sheiner E, Kapur A, Retnakaran R, et al. FIGO (International Federation of Gynecology and Obstetrics) postpregnancy initiative: long‐term maternal implications of pregnancy complications—follow‐up considerations. Int J Gynecol Obstet. 2019;147(S1):1–31.
- American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy, American College of Obstetricians and Gynecologists. Hypertens Pregn. 89:1122–1131.
- Young B, Hacker MR, Rana S. Physicians’ knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012;31(1):50–58.
- Nijdam M-E, Timmerman MR, Franx A, et al. Cardiovascular risk factor assessment after pre-eclampsia in primary care. BMC Fam Pract. 2009;10(1):PMC2796641.
- Keely E, Clark H, Karovitch A, et al. Research screening for type 2 diabetes following gestational diabetes family physician and patient perspectives. Can Fam Physician • Le Médecin de Famille Canadien. 2010;56:558–563.
- ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–e64.